Journavx 50 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FQT8U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,021
Award facts
- Contract value 100% obligated
- $3,020.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,020.90 to Amerisourcebergen Drug Corp (subsidiary of Cencora, Inc.) on January 8, 2026, for the supply of Journavx 50 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 9, 2026. The work will be performed at Amerisourcebergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under Amerisourcebergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
Amerisourcebergen Drug Corp serves as a critical federal pharmaceutical vendor, regularly supplying prescription medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military and veteran healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to meet government procurement requirements through open competition, with delivery orders ranging substantially in value and covering diverse pharmaceutical products. The parent company, Cencora, Inc., also maintains a larger Indefinite Delivery Contract with DLA valued at up to $999,999,999.00 through December 31, 2031, further establishing the organization's role as a primary distributor of essential pharmaceutical and medical commodities to federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FQT8U?
SPE2DR26FQT8U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FQT8U worth?
The government has obligated $3,021 on SPE2DR26FQT8U.
Is contract SPE2DR26FQT8U an order under another contract?
Yes. SPE2DR26FQT8U is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQT8U competed?
The extent of competition for SPE2DR26FQT8U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award